MAIA Biotechnology, Inc.

EDGAR

Annual consolidated revenue for 2024: about USD 0, using the latest filing vintage with reviewed corrections applied. Corrected values apply reviewed corrections and remain separate from issuer reports. The previous period, 2023, was about USD 0.

Watchlist

Holdings and insider activity

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.

Window: transactions dated on or after 2025-11-19.

Open-market purchases (code P)
34 transactions, 1,066,200 shares
Sum of shares × price per share: 1,275,877.189
Open-market sales (code S)
0 transactions, — shares

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

  • 2026-11-16 Smith Stan P 18,782 1.00
  • 2026-11-16 Vitoc Vlad P 39,600 1.00
  • 2026-11-13 Smith Stan P 81,218 1.00
  • 2026-11-13 Vitoc Vlad P 60,400 1.00
  • 2026-09-30 Guerrero Ramiro A 32,012 0

5% holders (Schedule 13D and 13G)

  • Solas Capital Management, LLC 4.9% SCHEDULE 13G/A 06/30/2026
  • FREDERICK TUCKER GOLDEN 4.9% SCHEDULE 13G/A 06/30/2026
  • Solas Capital Management, LLC 7.1% SCHEDULE 13G 03/31/2026

See all insider transactions

Latest quarter

Revenue

0

2022 Q4 ·

Exact inputs and evidence

Operating cash flow

-2.95 million

2022 Q4 ·

Exact inputs and evidence
  • Operating Cash Flow: -12096104 USD Source
  • Operating Cash Flow: -9146390 USD Source
Cash and cash equivalents
0 USD Source
Exact value

0 USD

Long-term debt including current maturities
0 USD
Exact inputs and evidence

0 USD

  • Long-term debt including current maturities: 0 USD Source
Shares outstanding
61.7 million shares Source
Exact value

61741946 shares

Reported share-count change

79.22% · 27.3 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence
  • 34451153 shares · 2025-09-30· Source
  • 61741946 shares · 2026-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-25.1 million USD

2025-10-01 – 2026-09-30

Exact inputs and evidence
  • Net income: -22396172 USD · 2025-01-01 – 2025-12-31 Source
  • Net income: -18767410 USD · 2025-01-01 – 2025-09-30 Source
  • Net income: -6369652 USD · 2026-01-01 – 2026-03-31 Source
  • Net income: -7943587 USD · 2026-04-01 – 2026-06-30 Source
  • Net income: -7178137 USD · 2026-07-01 – 2026-09-30 Source

Operating cash flow

-25.4 million USD

2025-10-01 – 2026-09-30

Exact inputs and evidence
  • Operating cash flow: -18844598 USD · 2025-01-01 – 2025-12-31 Source
  • Operating cash flow: -11824127 USD · 2025-01-01 – 2025-09-30 Source
  • Operating cash flow: -5311328 USD · 2026-01-01 – 2026-03-31 Source
  • Operating cash flow: -12061383 USD · 2026-01-01 – 2026-06-30 Source
  • Operating cash flow: -5311328 USD · 2026-01-01 – 2026-03-31 Source
  • Operating cash flow: -18372402 USD · 2026-01-01 – 2026-09-30 Source
  • Operating cash flow: -12061383 USD · 2026-01-01 – 2026-06-30 Source

Company performance

Up to ten complete financial years · consolidated figures

Latest filing vintage with reviewed corrections applied; these values remain separate from issuer-reported figures. Annual charts exclude incomplete years.

Latest filing recorded: 2026-11-17.

Financial data available through: 2024-12-31.

Financial coverage is incomplete. Newer filings are recorded, but comparable financial figures for those periods are not available here yet.

Coverage by financial measure
  • Revenue: 4 of 11 periods available· newest 2024-12-31
  • Operating income: 5 of 11 periods available· newest 2024-12-31
  • Net income: 1 of 11 periods available· newest 2024-12-31
  • Operating cash flow: 5 of 11 periods available· newest 2024-12-31
  • capital expenditure: No compatible figures in this window
  • Total assets: 4 of 11 periods available· newest 2024-12-31
  • Total liabilities: 4 of 11 periods available· newest 2024-12-31
  • Current assets: 4 of 11 periods available· newest 2024-12-31
  • Current liabilities: 4 of 11 periods available· newest 2024-12-31
  • Cash and cash equivalents: 4 of 11 periods available· newest 2024-12-31
  • long term debt: No compatible figures in this window
  • Shares outstanding: 4 of 11 periods available· newest 2024-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Revenue

    USD 0

    Prior period

    USD 0

    –

    Current period

    USD 0

    –

    Exact inputs and evidence

    0 − 0 = 0 USD

    0 USD · 2023-01-01 – 2023-12-31

    Inspect prior input Prior source

    0 USD · 2024-01-01 – 2024-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    −USD 2.63 million

    Prior period

    −USD 13.07 million

    –

    Current period

    −USD 15.7 million

    –

    Exact inputs and evidence

    -15704461 − -13071016 = -2633445 USD

    -13071016 USD · 2023-01-01 – 2023-12-31

    Inspect prior input Prior source

    -15704461 USD · 2024-01-01 – 2024-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Net income, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2024 2024-01-01 – 2024-12-31

  • Revenue USD 0
  • Operating costs Derived USD 16.96 million
  • Operating income −USD 16.96 million
  • Tax, interest and other Derived USD 6.3 million
  • Net income −USD 23.25 million

Cash

  • Operating cash flow −USD 15.7 million
  • Capital expenditure Unavailable An input is unavailable.
  • Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2021 Not shown: operating income or net income is not reported.
  • 2022 Not shown: operating income or net income is not reported.
  • 2023 Not shown: operating income or net income is not reported.
  • 2024 Not shown: operating income or net income is not reported.
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2021 2021-01-01 – 2021-12-310 7786627 Derived -7786627 UnavailableUnavailableUnavailable
Source
2022 2022-01-01 – 2022-12-310 16176201 Derived -16176201 UnavailableUnavailableUnavailable
Source
2023 2023-01-01 – 2023-12-310 20182381 Derived -20182381 UnavailableUnavailableUnavailable
Source
2024 2024-01-01 – 2024-12-310 16957210 Derived -16957210 6297446 Derived -23254656 Unavailable
Source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 0 2024
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.1.10.80.50.30.02021202220232024
Values and sources
Revenue values and source evidence
PeriodSeriesValue(USD)Source evidence
2021Revenue0
2022Revenue0
2023Revenue0
2024Revenue0

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2021Year over yearNo prior comparable period
2022Year over yearNo prior comparable period
2023Year over yearNo prior comparable period
2024Year over yearNo prior comparable period

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2021Operating marginNot reported
2022Operating marginNot reported
2023Operating marginNot reported
2024Operating marginNot reported
2021-12-31Net marginNot reported
2022-12-31Net marginNot reported
2023-12-31Net marginNot reported
2024Net marginNot reported
2021Free cash flow marginNot reported
2022Free cash flow marginNot reported
2023Free cash flow marginNot reported
2024Free cash flow marginNot reported

Operating cash flow

Cash generated by the company’s normal business operations.

USD -15.7M 2024
Operating cash flow historyCash generated by the company’s normal business operations. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.1.3M-3.3M-7.9M-12.4M-17.0M2021202220232024
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2021Operating cash flow-4122896
2022Operating cash flow-12096104
2023Operating cash flow-13071016
2024Operating cash flow-15704461

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2021Free cash flowUnavailable
2022Free cash flowUnavailable
2023Free cash flowUnavailable
2024Free cash flowUnavailable

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

64.2% 2024
Liabilities to assets historyTotal liabilities as a share of total assets. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.101%76%51%25%0%2021202220232024
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2021Liabilities / assets18.9%
2022Liabilities / assets29.2%
2023Liabilities / assets93.7%
2024Liabilities / assets64.2%

Current assets to current liabilities

Current assets divided by current liabilities.

2.65× 2024
Current assets to current liabilities historyCurrent assets divided by current liabilities. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.5.37×4.03×2.69×1.34×0.00×2021202220232024
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2021Current assets / current liabilities4.97×
2022Current assets / current liabilities3.61×
2023Current assets / current liabilities1.53×
2024Current assets / current liabilities2.65×

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2020 2020-01-01 – 2020-12-31
Unavailable Not reported for this period.
−USD 1.84 million
Exact value

Exact value: -1844163 USD

2020-01-01 – 2020-12-31: -1844163 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2021 2021-01-01 – 2021-12-31
Unavailable Not reported for this period.
−USD 4.12 million
Exact value

Exact value: -4122896 USD

2021-01-01 – 2021-12-31: -4122896 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2022 2022-01-01 – 2022-12-31
Unavailable Not reported for this period.
−USD 12.1 million
Exact value

Exact value: -12096104 USD

2022-01-01 – 2022-12-31: -12096104 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2023 2023-01-01 – 2023-12-31
Unavailable Not reported for this period.
−USD 13.07 million
Exact value

Exact value: -13071016 USD

2023-01-01 – 2023-12-31: -13071016 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2024 2024-01-01 – 2024-12-31
−USD 23.25 million
Exact value

Exact value: -23254656 USD

2024-01-01 – 2024-12-31: -23254656 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 15.7 million
Exact value

Exact value: -15704461 USD

2024-01-01 – 2024-12-31: -15704461 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

33 filings · 1,085 latest values · 1,085 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001878313, 1878313, MAIA, edgar:1878313

Also known as MAIA BIOTECHNOLOGY, INC., MAIA Biotechnology, Inc.